Omega-3 and Aspirin Combo Matches Antibiotics for Severe Gum Disease

If your dentist has used the word periodontitis, you already know the standard playbook: a deep cleaning, and often a two-week course of two antibiotics, in hopes the pockets around your teeth close up before more bone is lost. A new year-long clinical trial out of Brazil offers a genuine alternative to that antibiotic step, not a replacement for the cleaning, but a swap for the pills. Patients who took a daily combination of high-dose fish oil and low-dose aspirin for six months ended up just as likely to hit the treatment goal as patients who took antibiotics instead, without the resistance risk of a two-drug antibiotic course.

Key takeaways

• In a year-long trial of 109 patients with severe periodontitis, a daily combination of 3 grams of omega-3 fish oil and 100 milligrams of aspirin worked about as well as antibiotics: 57.7 percent versus 58.6 percent of patients reached the treatment goal, compared with 23.1 percent on placebo.
• Combining the antibiotics and the fish oil and aspirin regimen did not outperform either one alone, suggesting each may already approach a ceiling of benefit in this population.
• Caveat: the trial enrolled about half its planned sample, excluded smokers and people with diabetes, and is the first study of its kind, not yet independently replicated.
• This is not a green light to self-treat gum disease with supplements; the doses studied were high, aspirin carries risks, and every patient in the trial also received professional deep cleaning.

Omega-3 Plus Aspirin Matched Antibiotic Results

In a randomized, placebo-controlled trial published in the Journal of Periodontology, researchers found that a daily combination of 3 grams of omega-3 fish oil and 100 milligrams of aspirin, taken for six months, produced clinical improvement statistically indistinguishable from a standard two-week course of the antibiotics metronidazole and amoxicillin. The trial, led by Nidia C. Castro dos Santos, Magda Feres, and colleagues across Guarulhos University, the University of Taubaté, and the University of São Paulo, is the first double-blind RCT to test the fish oil and aspirin combination, the antibiotic combination, and both together, all against a placebo, in the same patients under identical conditions. At the one-year mark, 57.7 percent of patients on the fish oil and aspirin combination (called IM, for immunomodulator, in the study) had met the treatment goal, defined as a probing depth (PD, the distance from the gumline to the bottom of a gum pocket) of 5 millimeters or more at no more than four sites in the mouth. That compared with 58.6 percent on antibiotics, 57.1 percent on both treatments combined, and just 23.1 percent on placebo alone (p = 0.023 overall, p < 0.001 for each active treatment versus placebo).

Why This Matters for Severe Gum Disease

Severe periodontitis, the advanced stage of gum disease, is a leading cause of adult tooth loss, and failing to reach a stable, controlled state after treatment is linked to a 2.6 times higher risk of eventually losing teeth, according to a separate meta-analysis of nearly 13,000 patients cited in the study, and tooth loss itself has been tied to broader problems including cognitive decline and cardiovascular disease. The standard adjunct to deep cleaning for severe cases has long been a two-week course of metronidazole and amoxicillin, but about a third of patients still do not reach the treatment goal even with antibiotics on board, and every added antibiotic course contributes to the broader problem of antibiotic resistance.

Inside the Three-Center, Placebo-Controlled Design

The trial enrolled 109 patients (66 women, 43 men, average age 48) across three Brazilian university dental centers between February 2022 and February 2024, randomly assigning each to one of four arms: placebo, antibiotics only, fish oil and aspirin only, or both combined. Every patient, regardless of group, first received subgingival instrumentation (SI, the deep cleaning that removes plaque and hardened deposits from below the gumline), and every patient swallowed the same number of capsules, real or placebo, so neither patients nor the examiners measuring their gums knew who was on which regimen. The researchers had originally planned to enroll 200 patients, enough for 80 percent statistical power, but pandemic-era disruptions and funding constraints in Brazil limited enrollment to 109, leaving the trial at roughly 75 percent power.

What This Means if You Have Gum Disease

This trial does not mean fish oil and aspirin have replaced antibiotics as the default periodontitis treatment, or that patients should start dosing themselves with either before talking to a dentist or physician. The 3 gram omega-3 and 100 milligram aspirin doses used here are well above typical over-the-counter fish oil serving sizes, and low-dose aspirin can interact with blood thinners and raise bleeding risk, so it is not appropriate for everyone; both were prescribed and monitored as part of a supervised trial. Omega-3s are thought to work by promoting the resolution of inflammation and tissue repair, rather than by attacking bacteria directly the way antibiotics do. What the result does support is a conversation: patients who are wary of antibiotics, who have had side effects from them before, or whose dentist is weighing options for a severe case, now have a published, placebo-controlled data point suggesting a non-antibiotic path is at least plausible, and worth asking about explicitly.

Caveats: One Trial, Narrow Patient Population

The biggest caveat is size: with 109 patients analyzed instead of the planned 200, the study fell short of its intended statistical power, and it was explicitly not powered to compare the three active treatment arms directly against one another, only against placebo. The trial also excluded smokers, people with diabetes, and anyone with other systemic diseases that affect healing, so the results describe an otherwise healthy population and may not generalize to the smokers and diabetics who often have the worst periodontitis outcomes. This is, by the authors' own account, the first randomized trial of its kind; it has not yet been independently replicated.

What Comes Next for Host-Modulating Therapy

The authors are calling for larger, more diverse follow-up trials, ones that include smokers and patients with diabetes, extend follow-up beyond one year, and are specifically powered to compare the antibiotic and fish oil and aspirin regimens head to head rather than each against placebo alone. They also want future work to add microbiological and immunological measurements, to help explain why combining both treatments did not outperform either one alone, a result the researchers attribute to a possible ceiling effect.

Common Questions

Can I just take fish oil and aspirin instead of antibiotics for gum disease? Not without medical guidance. The trial used prescribed doses, 3 grams of omega-3 and 100 milligrams of aspirin daily for six months, alongside professional deep cleaning, and aspirin carries bleeding risks that need individual evaluation.

What dose of omega-3 and aspirin did researchers use? Patients in the combination arm took 3 grams of omega-3 fish oil plus 100 milligrams of aspirin every day for six months, on top of the same deep cleaning every other group received.

Did combining antibiotics with omega-3 and aspirin work better than either alone? No. All three active treatment groups, antibiotics, fish oil and aspirin, or both together, reached the treatment goal at similar rates, roughly 57 to 59 percent, and combining them showed no added benefit over either one individually.

Who was excluded from this study? Smokers, pregnant or breastfeeding people, and anyone with diabetes or other systemic diseases affecting healing were excluded, so the findings apply most directly to otherwise healthy adults with severe gum disease.

References

1. Nidia C. Castro dos Santos, Rafael N. de Brito Silva, Fernanda S. Colombo, et al. (2026). Immunomodulators, associated or not with systemic antibiotics, to treat periodontitis: A 1‐year multicenter, placebo‐controlled, double‐blind, randomized clinical trial. Journal of Periodontology. https://doi.org/10.1002/jper.70081
2. Sam Asher, Ruth Stephen, Päivi Mäntylä, Anna Liisa Suominen, Alina Solomon (2022). Periodontal health, cognitive decline, and dementia: A systematic review and meta‐analysis of longitudinal studies. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.17978